Practicing oncologists typically rely on data from clinical trials as a source for making treatment-related decisions. However, new or rare oncology areas are often limited by the clinical trial data available, as agents for some of these indications can be approved on the basis of phase II trials, ie, an inherently smaller patient population. This […]

Oncology is one of the pharma industry’s largest and most appealing sectors, creating a crowded market. In fact, most major pharma companies desire to be seen as leaders in oncology innovation. However, bulging pipelines for the development of oncology drugs find companies competing with similar products and finding new applications for existing targets. The most […]

Advances in technology will have a sizable impact on the oncology sector in the next decade. The trends we will identify in this post include advances in drug development (specifically targeted or combination therapies), use of real-world evidence, and new technologies used in the treatment and guidance of cancer care. Mobile medical apps are a […]

Creative leadership is crucial for helping your company make moves toward innovation in an industry full of challenges, including healthcare reform, changes in technology, and consumer expectations. Aligning your organization’s goals with key stakeholders is more important than ever. In nurturing stakeholder relationships that will help promote and introduce innovative practices, position yourself as creative—this […]